section 1 - World Intellectual Property Organization
section 1 - World Intellectual Property Organization
section 1 - World Intellectual Property Organization
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
44/2002<br />
31 Oct/oct 2002 PCT Gazette - Section I - Gazette du PCT 21629<br />
FI FR GB GR IE IT LU MC NL PT SE TR);<br />
OA(BFBJCFCGCICMGAGNGQGW<br />
ML MR NE SN TD TG).<br />
(51) 7 A61K 31/5575, 31/352, 45/00, A61P 27/06,<br />
27/02, 43/00<br />
(11) WO 02/085372 (13) A1<br />
(21) PCT/JP02/03292<br />
(22) 2 Apr/avr 2002 (02.04.2002)<br />
(25) ja (26) ja<br />
(30) 2001-121295 19 Apr/avr 2001 JP<br />
(19.04.2001)<br />
(43) 31 Oct/oct 2002 (31.10.2002)<br />
(54) MEDICINES AND MEDICINAL KITS<br />
MEDICAMENTS ET TROUSSES MEDI-<br />
CALES<br />
(71) TEIKA PHARMACEUTICAL CO.,<br />
LTD. [JP/JP]; 3-27, Arakawa 1-chome,<br />
Toyama-shi, Toyama 930-0982 (JP). KOWA<br />
COMPANY LTD. [JP/JP]; 6-29, Nishiki<br />
3-chome, Naka-ku, Nagoya-shi, Aichi<br />
460-8625 (JP).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) ORIHASHI, Masahiro [JP/JP]; 739-14,<br />
Fujinoki, Toyama-shi, Toyama 739-14<br />
(JP). KOIKE, Junpei [JP/JP]; Room<br />
307, Residence K & I, 3-3-21, Nagae,<br />
Toyama-shi, Toyama 930-0974 (JP). MA-<br />
SUDA,Kanako [JP/JP]; 158-3, hongoumachi<br />
5-ku, Toyama-shi, Toyama 939-8045 (JP).<br />
(74) ONO, Nobuo et al. / etc.; Mitobe Bldg. 4F,<br />
1-13-1, Kandaizumi-cho, Chiyoda-ku, Tokyo<br />
101-0024 (JP).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MA MD MG MK<br />
MN MW MX MZ NO NZ OM PH PL PT RO<br />
RU SD SE SG SI SK SL TJ TM TN TR TT<br />
TZ UA UG US UZ VN YU ZA ZM ZW.<br />
(84)AP(GHGMKELSMWMZSDSLSZTZ<br />
UG ZM ZW); EA (AM AZ BY KG KZ MD<br />
RU TJ TM); EP (AT BE CH CY DE DK ES<br />
FI FR GB GR IE IT LU MC NL PT SE TR);<br />
OA(BFBJCFCGCICMGAGNGQGW<br />
ML MR NE SN TD TG).<br />
Declaration / Déclaration :<br />
(t) for all designations / pour toutes les<br />
désignations<br />
(51) 7 A61K 31/56, 31/58, 31/66<br />
(11) WO 02/085373<br />
(21) PCT/US02/12489<br />
(13) A1<br />
(22) 22 Apr/avr 2002 (22.04.2002)<br />
(25) en (26) en<br />
(30) 09/841,426 24 Apr/avr 2001<br />
(24.04.2001)<br />
US<br />
(43) 31 Oct/oct 2002 (31.10.2002)<br />
(54) COMPOSITION AND METHODS FOR<br />
TREATMENT OF ASTHMA SYMP-<br />
TOMS AND REDUCING ADENO-<br />
SINE/ADENOSINE<br />
ELS<br />
RECEPTOR LEV-<br />
COMPOSITION ET METHODES SER-<br />
VANT A TRAITER DES SYMPTOMES<br />
DE L’ASTHME ET LA DIMINUTION<br />
DES NIVEAUX DES RECEPTEURS<br />
D’ADENOSINE/ADENOSINE<br />
(71) EAST CAROLINA UNIVERSITY<br />
[US/US]; Martha Van Scott, Office of<br />
Technology Transfer, The Brody School<br />
of Medicine, 186 Warren Life Sciences<br />
Bldg., Greenville, NC 27858 (US).<br />
(72) NYCE, Jonathan, W.; 1 Keithwood Court,<br />
Titusville, NJ 08560 (US).<br />
(74) AMZEL,Viviana; EpiGenesis Pharmaceuticals,<br />
Inc., 7 Clarke Drive, Cranbury, NJ 08512<br />
(US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MA MD MG MK<br />
MN MW MX MZ NO NZ OM PH PL PT RO<br />
RU SD SE SG SI SK SL TJ TM TN TR TT<br />
TZ UA UG UZ VN YU ZA ZM ZW.<br />
(84)AP(GHGMKELSMWMZSDSLSZTZ<br />
UG ZM ZW); EA (AM AZ BY KG KZ MD<br />
RU TJ TM); EP (AT BE CH CY DE DK ES<br />
FI FR GB GR IE IT LU MC NL PT SE TR);<br />
OA(BFBJCFCGCICMGAGNGQGW<br />
ML MR NE SN TD TG).<br />
(51) 7 A61K 31/56<br />
(11) WO 02/085374 (13) A1<br />
(21) PCT/US02/13407<br />
(22) 25 Apr/avr 2002 (25.04.2002)<br />
(25) en (26) en<br />
(30) 60/286,842 25 Apr/avr 2001<br />
(25.04.2001)<br />
(30) 10/131,834 24 Apr/avr 2002<br />
(24.04.2002)<br />
US<br />
US<br />
(43) 31 Oct/oct 2002 (31.10.2002)<br />
(54) ESTRIOL THERAPY FOR MULTIPLE<br />
SCLEROSIS AND OTHER AUTOIM-<br />
MUNE DISEASES<br />
THERAPIE A BASE D’ESTRIOL POUR<br />
LE TRAITEMENT DE LA SCLEROSE<br />
EN PLAQUES ET D’AUTRES MALA-<br />
DIES AUTO-IMMUNES<br />
(71) THE REGENTS OF THE UNIVERSITY<br />
OF CALIFORNIA [US/US]; 1111 Franklin<br />
Street, 5th Floor, Oakland, CA 94607-5200<br />
(US).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) VOSKUHL, Rhonda, R. [US/US]; 8852<br />
Ashcroft, West Hollywood, CA 90048 (US).<br />
(74) BROWN, Marc, E. et al. / etc.; McDermot,<br />
Will & Emery, Suite 3400, 2049 Century Park<br />
East, Los Angeles, CA 90067 (US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MA MD MG MK<br />
MN MW MX MZ NO NZ OM PH PL PT RO<br />
RU SD SE SG SI SK SL TJ TM TN TR TT<br />
TZ UA UG US UZ VN YU ZA ZM ZW.<br />
(84)AP(GHGMKELSMWMZSDSLSZTZ<br />
UG ZM ZW); EA (AM AZ BY KG KZ MD<br />
RU TJ TM); EP (AT BE CH CY DE DK ES<br />
FI FR GB GR IE IT LU MC NL PT SE TR);<br />
OA(BFBJCFCGCICMGAGNGQGW<br />
ML MR NE SN TD TG).<br />
Published / Publiée : (c)<br />
(51) 7 A61K 31/57, A61P 5/30 // (A61K 31/57,<br />
31:565)<br />
(11) WO 02/085375<br />
(21) PCT/FR02/01384<br />
(13) A1<br />
(22) 23 Apr/avr 2002 (23.04.2002)<br />
(25) fr (26) fr<br />
(30) 01/05557 25 Apr/avr 2001<br />
(25.04.2001)<br />
FR<br />
(43) 31 Oct/oct 2002 (31.10.2002)<br />
(54) NOVEL HORMONE COMPOSITION<br />
NOUVELLE COMPOSITION HORMO-<br />
NALE ET SON UTILISATION<br />
(71) LABORATOIRE THERAMEX [MC/MC];<br />
6, avenue Prince-Héréditaire-Albert,<br />
MC-98000 Monaco (MC).<br />
(71, 72) PARIS, Jacques [—/FR]; 31, avenue<br />
Cap de Croix, Bât. E, Porte 1, Le Clos de<br />
Cimiez, F-06100 Nice (FR). THOMAS,<br />
Jean-Louis [—/FR]; 16, rue Gabriel-Peri,<br />
F-94220 Charenton-le-Pont (FR).<br />
(74) BURTIN, Jean-François; Cabinet Gefib,<br />
82, rue Baudin, F-92300 Levallois Perret<br />
(FR).<br />
(81) AE AL AU BA BG BR CA CN CO CR CU<br />
CZ DZ EC EE HR HU ID IL IN IS JP KR LT<br />
LV MA MK MX NO NZ PH PL RO SG SI<br />
TN US VN YU ZA.<br />
(84)AP(GHGMKELSMWMZSDSLSZTZ<br />
UG ZM ZW); EA (AM AZ BY KG KZ MD<br />
RUTJTM);EP(ATBECHCYDEDKES<br />
FI FR GB GR IE IT LU MC NL PT SE TR);<br />
OA(BFBJCFCGCICMGAGNGQGW<br />
ML MR NE SN TD TG).<br />
Published / Publiée : (c)<br />
(51) 7 A61K 31/60, 31/18, 31/405, A61P 3/10,<br />
5/48, 9/08, 9/12, 29/00<br />
(11) WO 02/085376<br />
(21) PCT/CA02/00568<br />
(13) A2<br />
(22) 19 Apr/avr 2002 (19.04.2002)<br />
(25) en (26) en<br />
(30) 60/284,505 19 Apr/avr 2001<br />
(19.04.2001)<br />
US<br />
(43) 31 Oct/oct 2002 (31.10.2002)<br />
(54) A METHOD FOR DECREASING SU-<br />
PEROXIDE ANIONS PRODUCTION<br />
AND TREATMENT OF OXIDATIVE<br />
STRESS<br />
PROCEDE PERMETTANT DE RE-<br />
DUIRE LA PRODUCTION D’ANIONS<br />
DE SUPEROXYDE ET TRAITEMENT<br />
DE STRESS OXYDANT<br />
(71) UNIVERSITE DE MONTREAL<br />
[CA/CA]; 2900 Edouard-Montpetit,<br />
tréal, Québec H3T 1J4 (CA).<br />
Mon-<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) DE CHAMPLAIN, Jacques [CA/CA];<br />
1246 Lajoie, Outremont, Québec H2V 1P1<br />
(CA). WU, Rong [CA/CA]; 1067, place<br />
Guertin, Ville St. Laurent, Québec H4L 1X5<br />
(CA). EL MIDAOUI, Adil [CA/CA]; 70<br />
Crépeau, Apt. 301, Ville St. Laurent, Québec<br />
H4M 1N9 (CA).<br />
(74) OGILVY RENAULT; Attn: Cawthorn,<br />
Christian, Suite 1600, 1981 McGill College<br />
Avenue, Montreal, Québec H3A 2Y3 (CA).